Immuron
$0.00 (0.00%) Today
$0.00 (0.00%) As of 1:12 PM UTC after-hours
Why Robinhood?
You can buy or sell Immuron and other stocks, options, and ETFs commission-free!
About IMRN
Immuron Ltd. engages in the research and development of oral immunotherapy, and product sales which focuses on bovine-colostrum with antibodies of choice for the treatment and prevention of a range of infectious and immune modulated diseases. It operates through the following segments: Research and Development, and HyperImmune Products.The Research and Development segment involves the R&D projects performed in Australia, Israel, and United States.
CEO
Jerry Kanellos
Employees
—
Headquarters
Carlton, Victoria (VIC)
Founded
1994
IMRN Key Statistics
Market Cap
28.17M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
—
High Today
—
Low Today
—
Open Price
—
Volume
0.00
52 Week High
$28.99
52 Week Low
$1.92
IMRN Earnings
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Aug 15, Pre-Market